Overall haemostasis potential assays performed in thrombophilic plasma: The effect of preactivating protein C and antithrombin

Thrombosis Research

Volumn 108, Issue 5-6, 2002, Pages 323-328

  Andresen, Marianne S ^a   Iversen, Nina ^b   Abildgaard, Ulrich ^a  

^a AKER UNIVERSITY HOSPITAL   (Norway)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

Blood coagulation; Fibrin generation; Laboratory method; Protein S; Thrombin; Thrombophilia

Indexed keywords

ANTITHROMBIN; BLOOD CLOTTING FACTOR 5 LEIDEN; FIBRIN; PENTASACCHARIDE; PROTEIN C; PROTEIN S; WARFARIN; ANTITHROMBIN III; BLOOD CLOTTING FACTOR 5;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEMOSTASIS; HUMAN; HUMAN TISSUE; MALE; MUTATION; PLASMA; PREECLAMPSIA; PREGNANCY; PROTEIN DEFICIENCY; PROTEIN POLYMERIZATION; THROMBOPHILIA; BLOOD; BLOOD CLOTTING TEST; CASE CONTROL STUDY; FAMILY HEALTH; GENETICS; METABOLISM; METHODOLOGY; MIDDLE AGED; PHYSIOLOGY; PROTEIN S DEFICIENCY;

ADULT; AGED; ANTITHROMBIN III; AREA UNDER CURVE; BLOOD COAGULATION TESTS; CASE-CONTROL STUDIES; FACTOR V; FAMILY HEALTH; FEMALE; FIBRIN; HEMOSTASIS; HUMANS; MALE; MIDDLE AGED; PREGNANCY; PROTEIN C; PROTEIN S DEFICIENCY; THROMBOPHILIA; WARFARIN;

EID: 0037829841     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(03)00067-7     Document Type: Article

References (15)

1. He S., Bremme K., Blombäck M. A laboratory method for determination of overall haemostatic potential in plasma: I. Method design and preliminary results. Thromb. Res. 96:1999;145-156.
2. He S., Antovic A., Blombäck M. A laboratory method for determination of overall haemostatic potential in plasma: II. Modifications for routine use. Thromb. Res. 103:2001;355-361.
3. Bremme K., Österlund E., Almqvist I., Heinonen K., Blombäck M. Enhanced thrombin generation and fibrinolytic activity in normal pregnancy and the puerperium. Obstet. Gynecol. 80:1992;132-137.
4. Faught W., Garner P., Jones G., Ivery B. Changes in protein C and protein S levels in normal pregnancy. Am. J. Obstet. Gynecol. 172:1995;147-150.
5. Lindoff C., Ingemarssen I., Martinsson G., Segelmark M., Thysell H., Åstedt B. Preeclampsia is associated with a reduced response to activated protein C. Am. J. Obstet. Gynecol. 176:1997;457-460.
6. Exner T., Vaasjoki R. Characterisation and some properties of the protein C activator from agkistrodon contortrix venom. Thromb. Haemost. 59:1988;40-44.
7. Béguin S., Choay J., Hemker H.C. The action of a synthetic pentasaccharide on thrombin generation in whole plasma. Thromb. Haemost. 61:1989;397-401.
8. Wolf M., Boyer-Neumann C., Martinoli J.-L., Leroy-Matheron C., Amiral J., Meyer D.et al. A new functional assay for human protein S activity using activated factor V as a substrate. Thromb. Haemost. 62:1989;1144-1145.
9. Bertina R.M. Factor V Leiden and other coagulation factor mutations affecting thrombotic risk. Clin. Chem. 43:1997;1678-1683.
10. Ødegaard O.R., Rosenlund B., Ervik E. Automated antithrombin III assay with a centrifugal analyser. Haemostasis. 7:1978;202-209.
11. Delorme M.A., Borrows R.F., Ofosu F.A., Andrew M. Thrombin regulation in mother and fetus. Semin. Thromb. Hemost. 18:1992;81-90.
12. Ødegaard O.R., Try K., Andersson T.R. Protein C: an automated assay. Haemostasis. 17:1987;109-113.
13. Kraus M., Noah M., Fickenscher K. The PCAT - a simple screening assay for assessing the functionality of the protein C anticoagulant pathway. Thromb. Res. 79:1995;217-222.
14. Hemker H.C., Giesen P.L.A., Ramjee M., Wagenvoord R., Béguin S. The thrombogram: monitoring thrombin generation in platelet rich plasma. Thromb. Haemost. 83:2000;589-591.
15. Duchemin J., Pittet J.L., Tartary M., Béguin S., Gaussem P., Alhenc-Gelas M.et al. A new assay based thrombin generation inhibition to detect both protein C and protein S deficiencies in plasma. Thromb. Haemost. 71:1994;331-338.